A Phase 2 randomized controlled trial (NCT07437547) is now recruiting to test BPC-157 in acute hamstring muscle strains the first rigorous human trial for this peptide
With a benign safety profile through six-month rodent toxicology and toxicology already taken to Phase II clinical evaluation in inflammatory bowel disease (PL 14736), BPC-157 stands as one of the few research peptides with a genuinely deep, reproducible evidence base
Heat exposure above 30 degrees Celsius Temperatures at or above 30 degrees Celsius (86 degrees Fahrenheit) cause rapid, often irreversible degradation
BPC-157 helps restore these junctions by up-regulating occludin and claudin
Which type(s) of B12 does this supplement contain, Methylcobalamin or Cyanocobalamin
It is not approved by the FDA, EMA, MHRA, PMDA, or any other regulatory authority for any therapeutic indication